What intramuscular dose of midazolam should be administered for status epilepticus in adults and children (dose per kilogram with maximum limit)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IM Midazolam Dosing for Status Epilepticus

For status epilepticus, administer intramuscular midazolam at 0.2 mg/kg with a maximum single dose of 10 mg in adults and 6 mg in children, and repeat every 10-15 minutes if seizures persist.

Pediatric Dosing

The evidence consistently supports 0.2 mg/kg IM as the standard dose for children with status epilepticus 1. This dose can be repeated every 10-15 minutes if seizures continue 1.

Maximum dose limits:

  • 6 mg per dose is the most commonly cited maximum in pediatric guidelines 1
  • Some protocols allow up to 10 mg total dose, though this is less standard 2

The FDA drug label confirms these parameters, noting that IM doses of 0.1-0.15 mg/kg are usually effective for sedation, with doses up to 0.5 mg/kg used for more anxious patients, though total doses typically don't exceed 10 mg 2.

Adult Dosing

For adults, the evidence supports the same 0.2 mg/kg IM dose with a maximum of 10 mg 3, 4. This represents the optimal balance between efficacy and safety, as higher doses increase sedation risk without proportional seizure control benefit.

Key Clinical Considerations

Timing is critical: IM midazolam should be administered immediately when IV access is difficult or delayed. The onset of action is rapid (within 5 minutes in children, 15 minutes in adults), making it superior to rectal diazepam for prehospital management 1, 3, 4.

Respiratory monitoring is mandatory: All patients require continuous oxygen saturation monitoring and readiness to provide respiratory support, as benzodiazepines can cause respiratory depression 1. This risk increases when midazolam is combined with opioids or other sedatives.

Repeat dosing: If the initial dose fails to stop seizures within 10-15 minutes, a second dose of 0.2 mg/kg (up to the same maximum) may be administered 1. After two IM doses without seizure cessation, the patient has established status epilepticus requiring IV antiseizure medications (levetiracetam or valproate) 3, 5.

Common Pitfalls to Avoid

Do not delay for IV access: The primary advantage of IM midazolam is avoiding delays associated with establishing IV access. Studies show IM midazolam has equal or superior efficacy to IV diazepam when accounting for time to administration 4, 6.

Do not underdose: Using doses below 0.2 mg/kg reduces efficacy. The evidence shows 0.1 mg/kg is insufficient for seizure control in status epilepticus, though it may be adequate for procedural sedation 2.

Do not use weight-based dosing without maximum limits: Always apply the maximum dose caps (6 mg in children, 10 mg in adults) to prevent excessive sedation and respiratory depression in larger patients.

Avoid flumazenil in seizure patients: While flumazenil can reverse midazolam's respiratory depression, it also reverses anticonvulsant effects and may precipitate recurrent seizures 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.